These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23249335)

  • 1. Inorganic nanoparticle biomolecular corona: formation, evolution and biological impact.
    Casals E; Puntes VF
    Nanomedicine (Lond); 2012 Dec; 7(12):1917-30. PubMed ID: 23249335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface engineering of inorganic nanoparticles for imaging and therapy.
    Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
    Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response.
    Maiorano G; Sabella S; Sorce B; Brunetti V; Malvindi MA; Cingolani R; Pompa PP
    ACS Nano; 2010 Dec; 4(12):7481-91. PubMed ID: 21082814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona?
    Liu W; Rose J; Plantevin S; Auffan M; Bottero JY; Vidaud C
    Nanoscale; 2013 Feb; 5(4):1658-68. PubMed ID: 23334428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake.
    Lartigue L; Wilhelm C; Servais J; Factor C; Dencausse A; Bacri JC; Luciani N; Gazeau F
    ACS Nano; 2012 Mar; 6(3):2665-78. PubMed ID: 22324868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.
    Wang H; Lin Y; Nienhaus K; Nienhaus GU
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1500. PubMed ID: 29071798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and characterization of the nanoparticle-protein corona.
    Monopoli MP; Pitek AS; Lynch I; Dawson KA
    Methods Mol Biol; 2013; 1025():137-55. PubMed ID: 23918335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature: the "ignored" factor at the NanoBio interface.
    Mahmoudi M; Abdelmonem AM; Behzadi S; Clement JH; Dutz S; Ejtehadi MR; Hartmann R; Kantner K; Linne U; Maffre P; Metzler S; Moghadam MK; Pfeiffer C; Rezaei M; Ruiz-Lozano P; Serpooshan V; Shokrgozar MA; Nienhaus GU; Parak WJ
    ACS Nano; 2013 Aug; 7(8):6555-62. PubMed ID: 23808533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the nanoparticle-protein corona on colloidal stability and protein structure.
    Gebauer JS; Malissek M; Simon S; Knauer SK; Maskos M; Stauber RH; Peukert W; Treuel L
    Langmuir; 2012 Jun; 28(25):9673-9. PubMed ID: 22524519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An environmental route of exposure affects the formation of nanoparticle coronas in blood plasma.
    Grunér MS; Kauscher U; Linder MB; Monopoli MP
    J Proteomics; 2016 Mar; 137():52-8. PubMed ID: 26546559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated approach to the study of the interaction between proteins and nanoparticles.
    Turci F; Ghibaudi E; Colonna M; Boscolo B; Fenoglio I; Fubini B
    Langmuir; 2010 Jun; 26(11):8336-46. PubMed ID: 20205402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
    Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
    Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Chemical Nature of Nanoparticle-Protein Interactions.
    Baimanov D; Cai R; Chen C
    Bioconjug Chem; 2019 Jul; 30(7):1923-1937. PubMed ID: 31259537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona.
    Piella J; Bastús NG; Puntes V
    Bioconjug Chem; 2017 Jan; 28(1):88-97. PubMed ID: 27997136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the protein corona on nanoparticles by FCS.
    Nienhaus GU; Maffre P; Nienhaus K
    Methods Enzymol; 2013; 519():115-37. PubMed ID: 23280109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona.
    Milani S; Bombelli FB; Pitek AS; Dawson KA; Rädler J
    ACS Nano; 2012 Mar; 6(3):2532-41. PubMed ID: 22356488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling.
    Sahneh FD; Scoglio CM; Monteiro-Riviere NA; Riviere JE
    Nanomedicine (Lond); 2015 Jan; 10(1):25-33. PubMed ID: 25032980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical tip: high-resolution isolation of nanoparticle-protein corona complexes from physiological fluids.
    Di Silvio D; Rigby N; Bajka B; Mayes A; Mackie A; Baldelli Bombelli F
    Nanoscale; 2015 Jul; 7(28):11980-90. PubMed ID: 26108682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.